From Medscape Oncology

Coverage from the

American Society of Clinical Oncology (ASCO) 2023

June 02 - 05, 2023; Chicago, Illinois and Virtual/Online

June 02 - 05, 2023 Chicago, Illinois and Virtual/Online

ASCO 2023 Omitting Radiation in Rectal Cancer: 'Less Is More' Many patients with locally advanced rectal cancer can skip radiotherapy to the pelvic area, and instead be treated with chemotherapy and then surgery, suggest the results from the PROSPECT trial.
Medscape Medical News, June 4, 2023
ASCO 2023 Oral Drug for Brain Tumor Could Change Treatment Landscape In patients with gliomas bearing IDH1/2 mutations, the brain barrier-crossing oral drug vorasidenib kept tumors at bay, and could be used instead of more toxic chemotherapies and radiation.
Medscape Medical News, June 4, 2023
ASCO 2023 'Huge Step Forward' in Advanced Ovarian Cancer Adding both durvalumab and olaparib to standard-of-care treatment in newly diagnosed non-BRCA mutated advanced ovarian cancer represents a 'huge step forward,' says one expert.
Medscape Medical News, June 3, 2023

Conference News

ASCO 2023 First or Second-Line CDK4/6 Inhibition in Breast Cancer?
MDedge News, June 8, 2023
ASCO 2023 PMBCL: Postremission, Patients May Safely Skip Radiation
MDedge News, June 8, 2023
ASCO 2023 Huge Underuse of Germline Testing for Cancer Patients
Medscape Medical News, June 7, 2023
ASCO 2023 CAR T-Cell Benefit in Lenalidomide-Refractory Myeloma
Medscape Medical News, June 6, 2023
ASCO 2023 Cancer Vaccines Poised to Unlock 'New Treatment Paradigm'
Reuters Health Information, June 6, 2023
ASCO 2023 T-DXd Active in Many Solid Tumors; 'Shift in Thinking'
Medscape Medical News, June 6, 2023
ASCO 2023 Safe to Stop Immunotherapy at 2 Years in Stable Lung Cancer
Medscape Medical News, June 6, 2023
ASCO 2023 AstraZeneca's Tagrisso Slashes Death Risk in Lung Cancer
Reuters Health Information, June 5, 2023
ASCO 2023 Antibody-Drug Conjugate MIRV Improves OS in Ovarian Cancer
MDedge News, June 5, 2023
ASCO 2023 Chemo Avoidance Pays Off for Some Women With HER2+ Early BC
MDedge News, June 5, 2023
ASCO 2023 Groundbreaking New Regimen for Advanced Hodgkin Lymphoma
MDedge News, June 5, 2023
ASCO 2023 Meta-Analysis Supports Ovarian Suppression in Breast Cancer
MDedge News, June 5, 2023
ASCO 2023 Reconnecting With Patients to 'Rediscover Joy of Oncology'
Medscape Medical News, June 5, 2023

ASCO 2023 Surgical De-escalation in Low-Risk Cervical Cancer
MDedge News, June 4, 2023
ASCO 2023 Omitting Radiation in Rectal Cancer: 'Less Is More'
Medscape Medical News, June 4, 2023
ASCO 2023 Oral Drug for Brain Tumor Could Change Treatment Landscape
Medscape Medical News, June 4, 2023
ASCO 2023 'Huge Step Forward' in Advanced Ovarian Cancer
Medscape Medical News, June 3, 2023
ASCO 2023 Ribociclib Forestalls Recurrence Also in Early Breast Cancer
Medscape Medical News, June 2, 2023
ASCO 2023 'Paradigm Shift': Luspatercept for MDS
MDedge News, June 1, 2023
ASCO 2023 Cross-Border US–Mexican Collaboration Drives Up ALL Survival
Medscape Medical News, May 25, 2023
ASCO 2023 Medicaid Expansion Closing Racial Gap in GI Cancer Deaths
Medscape Medical News, May 25, 2023
ASCO 2023 Phone Coach Helps Weight Loss in Patients With Breast Cancer
Medscape Medical News, May 25, 2023
ASCO 2023 Minimally Invasive vs Open Surgery in Pancreatic Cancer
Medscape Medical News, May 25, 2023
ASCO 2023 Upfront Pembro Plus Chemo Boost Survival in Cervical Cancer
Medscape Medical News, May 25, 2023
ASCO 2023 Biggest Cancer Meeting Is Back in Full Swing: ASCO 2023
Medscape Medical News, May 23, 2023

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Did an Unfair System Help ADAURA Win on Overall Survival?
H. Jack West, MD
High Hopes, Dashed Dreams: Progress in GI Cancers at ASCO
Mark A. Lewis

Popular News From ASCO 2022

Clinical Trials Stuck in the '80s: 'We Need to Embrace the Now' Clinical trial enrollment in oncology is very low. Neal Meropol, MD, argues that better use of technology can ramp up recruitment, make participation easier, and cut expenses for sponsors.
Medscape Medical News, Jun 14, 2022
Targeted Therapy an 'Important Advance' in Childhood Glioma Combining dabrafenib with trametinib markedly improved response rates and delayed progression over standard-of-care chemotherapy in pediatric BRAF V600-mutant low-grade glioma in a phase 2 trial.
Medscape Medical News, Jun 06, 2022
'Real-World' Data: Watchword or Accurate Description? Dr Kathy Miller discusses real-world data and whether reports accurately include these data.
Medscape Medical News, Dec 07, 2022

Previous Coverage